Come up with a name for your new list and we'll add to it:
ImmunGene raised a round of funding on November 07, 2013. Investors include
Ally Bridge Group.
ImmunGene is a privately held biotechnology company focused on the development of antibody-cytokine fusion technology and monoclonal antibody-based therapies to treat cancer, autoimmune disorders, and…